Discover how Evelo’s EDP1815 may prevent the progression of COVID-19. Learn More

Our Science
Our Portfolio
Publications
About Us
Investors
Careers
Contact

Flagship Launches Evelo with $35M to Explore Microbiome-Based Cancer Treatments

Bioworld - November 4, 2015

© Evelo Biosciences, Inc.
EVELO is a registered U.S. trademark of Evelo Biosciences, Inc.

Terms and Conditions of Use / Privacy Policy